Don Benson

Don Benson's research centers on multiple myeloma, a cancer of plasma cells in the bone marrow, with work spanning molecular profiling of tumors, clinical trials of new drug combinations, and immune system monitoring in cancer therapy. Recent studies include large-scale genetic classification of myeloma subtypes and phase 2/3 clinical trials testing antibody-based treatments like elotuzumab and modakafusp alfa. The work combines laboratory-based molecular research with patient-facing clinical trial design and immune monitoring methods.

Publication output has grown substantially over the past decade, rising from occasional years with few or no publications to a notably higher and more consistent output since 2022.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026